DHL wins US and Brazilian approval for European contract manufacturing
7 Feb 2011
DHL Supply Chain’s Contract Manufacturing operation at its Life Sciences & Healthcare Campus in Nijmegen, The Netherlands, has successfully passed two good manufacturing practice (GMP) audits. One was with the US FDA, the second with the Brazilian FDA ANVISA.
Arjen Hellinga, Business Development Manager at DHL Supply Chain in The Netherlands commented: “This approval is unique for a logistics provider. It allows a number of products to go through ‘late stage customization’ — including kitting and labeling — at our facility, prior to being exported to important markets outside the European Union such as the US and Brazil.”
At its shared-use Pharma Grade campus in Nijmegen, DHL manages supply chains for over 25 pharmaceutical and medical device companies. Strategically located in the South East of The Netherlands, the campus serves the Western European Healthcare market, enabling further consolidation and optimized inventory whilst maintaining excellent service levels.